Lisata Therapeutics, Inc. (LSTA) Operating margin 2015–2024
Lisata Therapeutics, Inc. (LSTA) operating margin by fiscal year — reported operating income divided by reported revenue.
-10711.2%FY2024 · since FY2015: -83.6% → -10711.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -10711.2% | -8470.3 pp |
| FY2023 | -2240.9% | — |
| FY2015 | -83.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LSTA financial trends
LSTA RevenueLSTA Net incomeLSTA Net marginLSTA Gross profitLSTA Gross marginLSTA Operating incomeLSTA Operating cash flowLSTA Free cash flowLSTA Capital expendituresLSTA Return on equityLSTA Stock buybacksLSTA Dividends paidLSTA Total assetsLSTA Total liabilitiesLSTA Shareholders’ equityLSTA overview →